TickerTalks
Browse all tickers →
TickerTalks›$GLAPF
GLGLAPF

Glanbia plc

$GLAPF·$6.7B·Packaged Foods·Consumer Defensive
$27.85+1.3%1Y+88.6%
Mentions · last 7 days
2026-08-06: 0 posts2026-08-07: 0 posts2026-08-08: 0 posts2026-08-09: 0 posts2026-08-10: 0 posts2026-08-11: 0 posts2026-08-12: 0 posts0
Price updated 3m ago·X counts updated 2d ago
GLGLAPF
$GLAPFGlanbia plc
$27.85+1.27%0 posts
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $GLAPF, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Proven numbersAcceleratingAI verdict · as of 2026-08-14

The move is getting stronger, with heavier trading behind it.

Glanbia hiked profit forecast on weight-loss-drug-driven protein-product demand — at 91% of range with +89% t12m.

Glanbia plc is the Irish-listed nutrition + performance-nutrition company (Optimum Nutrition, BSN brands + Nutritionals ingredients). $6.7B mcap, ADR $27.50, t12m +88.6%, sitting at 91% of the 52-week range — full breakout.

What's happening:

  • Q2 2026 (8/6) EPS $0.81 vs $0.70 est (+15.8% surprise). Prior three: +3.3%, -32.1%, -45.4% — the beat cadence has been variable.
  • Revenue Q2 $2.04B (+123% YoY — likely reflects reporting-cycle artifact), Q4-25 $2.03B (+142%), prior quarters were mixed.
  • 8/6 news: 'Glanbia hikes profit forecast as weight-loss drugs boost demand for protein products' — the GLP-1-driven protein-demand thesis in action.
  • Analyst estimates FY26 rev $3.54B, EPS $1.32 growing to FY28 $3.85B / $1.52 — modest projected growth despite the guide raise.
  • 28.2x TTM P/E is stretched for a packaged-food name.
  • ROE 12.3%.
  • No X sentiment sample.

What you're watching: continued GLP-1-driven protein-demand data points, any updated FY guide from management, and Optimum Nutrition + BSN category growth commentary.

What to watch: GLP-1-driven protein-demand data points, FY guide updates, and Optimum Nutrition + BSN category growth.

On the calendar: 2027-03-03 — FY earnings

no sentiment

Read the AI verdict + X sentiment for $GLAPF

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Irish nutrition company selling sports supplements under Optimum Nutrition and BSN brands globally, plus a US cheese and whey ingredients business.

Industry overviewAI analysisGenerated by AI from underlying data

Where Packaged Foods sits in its cycle right now — and what that implies for $GLAPF.

Packaged Foods · Consumer Defensive

No material change from last week — WEST's private-label coffee co-packing benefits from consumer switching from branded to value coffee, while DAR's food waste conversion to bio-based..

Industry benchmark

17-name peer basket
+13.0%YTD
+11.5%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
28.2How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
10.7%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
9.7%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
5.6%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
1.6Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
12.3%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
25.7%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.6Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Aug 6, 2026$0.81$0.70+15.8%
Q4 2025Feb 25, 2026$0.72$0.70+3.3%
Q2 2025Aug 13, 2025$0.39$0.57-32.1%
Q4 2024Feb 26, 2025$0.38$0.70-45.4%
Next earningsWed, Mar 3·consensus EPS $0.79

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$2.0B+123.4%26.6%10.1%$0.62$24.9M
Q4 FY25$2.0B+141.7%24.7%9.3%$0.35$351.9M
Q2 FY25$1.9B-57.8%27.3%6.5%$0.39$-17.0M
Q4 FY24$3.1B+123.7%29.5%5.1%$0.38$329.3M

Forward consensus

4-year forecast · up to 6 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$3.5B$3.5B – $3.6B$1.32$1.29 – $1.392
FY27$3.7B$3.6B – $3.9B$1.41$1.37 – $1.486
FY28$3.8B$3.8B – $4.0B$1.52$1.48 – $1.602
FY29$4.0B$4.0B – $4.2B$1.74$1.69 – $1.834

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.—Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.91%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+3.7%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+30.6%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatHigh float · 205.5M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.0% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.505-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.ListedOTCListed on an over-the-counter market (PNK / OTCQB / OTCQX), not a major exchange. Lower disclosure requirements and thinner liquidity.

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Glanbia hikes profit forecast as weight-loss drugs boost demand for protein productsreuters.com·8d ago

More in Packaged Foods

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$WYHG$KHC$MAMA$CPB$CAG$GIS$MKC$SENEA
Voices on X · last 7 days

No standout posts about $GLAPF on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport